Edgewise Therapeutics Earnings
NASDAQ: EWTXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Thu, Nov 5, 2026
Fiscal period
Sep/2026
EPS estimate
$-0.55
Edgewise Therapeutics earnings summary
Edgewise Therapeutics is scheduled to report Sep/2026 earnings on Nov 5, 2026, with analysts expecting EPS of $-0.55. In its most recent report on Aug 6, 2026 (Q2 2026), EWTX posted EPS of $-0.53. Across the last 16 reports, EWTX shares moved an average of 8.6% (in either direction) in the first trading session after results, rising 8 times and falling 8 times.
Summary generated from market data by MetaCap's automated system. Methodology
EWTX earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 6, 2026 | — | $-0.53 | — | +1.5% |
| May 7, 2026 | — | $-0.46 | — | -6.3% |
| Feb 26, 2026 | — | $-0.47 | — | -8.6% |
| Nov 6, 2025 | — | $-0.39 | — | +32.6% |
| Aug 7, 2025 | — | $-0.34 | — | +11.6% |
| May 8, 2025 | — | $-0.43 | — | +1.4% |
| Mar 3, 2025 | — | $-0.42 | — | -8.4% |
| Nov 7, 2024 | — | $-0.36 | — | -13.6% |
| Aug 8, 2024 | — | $-0.34 | — | +12.2% |
| May 9, 2024 | — | $-0.33 | — | -1.2% |
| Feb 22, 2024 | — | $-0.46 | — | -3.4% |
| Nov 9, 2023 | — | $-0.41 | — | +16.0% |
| Aug 10, 2023 | — | $-0.34 | — | +7.2% |
| May 11, 2023 | — | $-0.36 | — | -1.1% |
| Feb 23, 2023 | — | $-0.30 | — | -1.4% |
| Nov 3, 2022 | — | $-0.34 | — | +12.0% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.